{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:42:40Z","timestamp":1758400960216,"version":"3.30.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.rceng.2024.09.004","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T15:58:08Z","timestamp":1726934288000},"page":"664-669","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic approach to acute crises of hepatic porphyrias"],"prefix":"10.1016","volume":"224","author":[{"given":"M.","family":"Garrido Montes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pertusa Mataix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Garcia Morillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rceng.2024.09.004_bib0005","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jimd.12612","article-title":"Key terms and definitions in acute porphyrias: results of an international Delphi consensus led by the European porphyria network","volume":"46","author":"Stein","year":"2023","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.rceng.2024.09.004_bib0010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.rce.2019.10.012","article-title":"Protocol for patients with suspected acute porphyria [Article in English, Spanish]","volume":"220","author":"Castelb\u00f3n Fern\u00e1ndez","year":"2020","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rceng.2024.09.004_bib0125","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/00365510902935979","article-title":"Clinical aspects of acute intermittent porphyria in northern Sweden: a population-based study","volume":"69","author":"Bylesj\u00f6","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.rceng.2024.09.004_bib0150","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.medcli.2023.06.032","article-title":"Acute hepatic porphiria: epidemiology, classificacion and clinical profile [Article in English, Spanish]","volume":"1591","author":"Aguilera Peir\u00f3","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rceng.2024.09.004_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-020-01089-5","article-title":"Correction to: porphyric neuropathy: pathophysiology, diagnosis, and updated management","volume":"21","author":"Kazamel","year":"2020","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.rceng.2024.09.004_bib0020","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.29313","article-title":"Acute hepatic porphyrias: recommendations for evaluation and long-term management","volume":"66","author":"Balwani","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.rceng.2024.09.004_bib0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/8904_2015_411","article-title":"Audit of the use of regular haem arginate infusions in patients with acute porphyria to prevent recurrent symptoms","volume":"22","author":"Marsden","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.rceng.2024.09.004_bib0030","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s12325-008-0094-y","article-title":"Physicochemical properties, pharmacokinetics, and pharmacodynamics of intravenous hematin: a literature review","volume":"25","author":"Siegert","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.rceng.2024.09.004_bib0035","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1073\/pnas.68.11.2725","article-title":"Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin","volume":"68","author":"Bonkowsky","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rceng.2024.09.004_bib0135","first-page":"361","article-title":"The inactivation of hemostatic factors by hematin","volume":"102","author":"Green","year":"1983","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.rceng.2024.09.004_bib0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-2007-1007140","article-title":"Acute porphyria: treatment with heme","volume":"18","author":"Tenhunen","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rceng.2024.09.004_bib0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymgme.2022.01.002","article-title":"Givosiran in acute intermittent porphyria: a personalized medicine approach","volume":"135","author":"Poli","year":"2022","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rceng.2024.09.004_bib0045","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jhep.2023.06.013","article-title":"Efficacy and safety of givosiran for acute hepatic porphyria: final results of the randomized phase III ENVISION trial","volume":"79","author":"Kuter","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.rceng.2024.09.004_bib0050","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.medcli.2023.06.016","article-title":"Acute intermittent porphyria: acute flare-up resolved with givosiran","volume":"161","author":"Balado Gonz\u00e1lez","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rceng.2024.09.004_bib0100","first-page":"276","article-title":"Personalized dosage of Givosiran in acute intermittent porphyria [Article in English, Spanish]","volume":"S0025-7753","author":"Garrido Montes","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rceng.2024.09.004_bib0160","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/17474124.2022.2110469","article-title":"Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran","volume":"16","author":"Ventura","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.rceng.2024.09.004_bib0055","doi-asserted-by":"crossref","first-page":"e0327","DOI":"10.1097\/HC9.0000000000000327","article-title":"Long-term management and treatment of acute intermittent porphyria with recurring attacks using pharmacological prophylaxis","volume":"7","author":"Kuo","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.rceng.2024.09.004_bib0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/lt.25959","article-title":"Liver transplantation for acute intermittent porphyria","volume":"27","author":"Lissing","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.rceng.2024.09.004_bib0065","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/lt.21261","article-title":"Liver transplantation for porphyria: who, when, and how?","volume":"13","author":"Seth","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.rceng.2024.09.004_bib0070","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(04)15646-8","article-title":"Liver transplantation as a cure for acute intermittent porphyria","volume":"363","author":"Soonawalla","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.rceng.2024.09.004_bib0075","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/L18-0623","article-title":"Recurrence of acute intermittent porphyria after liver transplantation","volume":"170","author":"Al-Samkari","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rceng.2024.09.004_bib0145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0044-1787076","article-title":"Understanding hepatic porphyrias: symptoms, treatments, and unmet needs","volume":"44","author":"Balogun","year":"2024","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.rceng.2024.09.004_bib0165","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jhep.2016.05.012","article-title":"Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria","volume":"65","author":"D\u2019Avola","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.rceng.2024.09.004_bib0170","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41591-018-0199-z","article-title":"Systemic messenger RNA as an etiological treatment for acute intermittent porphyria","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.rceng.2024.09.004_bib0080","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.21037\/atm-20-1529","article-title":"Management of hyponatremia associated with acute porphyria\u2014proposal for the use of tolvaptan","volume":"8","author":"Solares","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.rceng.2024.09.004_bib0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7196\/SAMJ.2016.v106i1.10118","article-title":"Severe porphyric neuropathy\u2014importance of screening for porphyria in Guillain-Barr\u00e9 syndrome","volume":"106","author":"Schutte","year":"2015","journal-title":"S Afr Med J"},{"key":"10.1016\/j.rceng.2024.09.004_bib0090","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/brb3.2389","article-title":"Acute porphyrias \u2014 a neurological perspective","volume":"11","author":"Gerischer","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.rceng.2024.09.004_bib0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.7326\/0003-4819-125-5-199609010-00023","article-title":"Cortical brain lesions in acute intermittent porphyria","volume":"125","author":"Sze","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rceng.2024.09.004_bib0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000330683","article-title":"Neurological complications of acute intermittent porphyria","volume":"66","author":"Kuo","year":"2011","journal-title":"Eur Neurol"},{"key":"10.1016\/j.rceng.2024.09.004_bib0095","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.nrl.2014.11.003","article-title":"Neuroimaging abnormalities in a patient with posterior reversible encephalopathy syndrome due to acute intermittent porphyria [Article in English, Spanish]","volume":"31","author":"Rivero Sanz","year":"2016","journal-title":"Neurologia"},{"key":"10.1016\/j.rceng.2024.09.004_bib0105","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMc2026458","article-title":"Givosiran for acute intermittent porphyria","volume":"383","author":"Gom\u00e1-Garc\u00e9s","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2024.09.004_bib0110","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.medcli.2023.04.038","article-title":"Long-term complications of acute hepatic porphyrias","volume":"159","author":"Garc\u00eda Morillo","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rceng.2024.09.004_bib0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.rce.2024.04.003","article-title":"PICO questions and DELPHI methodology for improving the management of patients with acute hepatic porphyria","volume":"224","author":"Riera-Mestre","year":"2024","journal-title":"Rev Clin Esp (Barc)"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887424001231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887424001231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T09:00:38Z","timestamp":1733043638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2254887424001231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2254887424001231"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2024.09.004","relation":{},"ISSN":["2254-8874"],"issn-type":[{"type":"print","value":"2254-8874"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic approach to acute crises of hepatic porphyrias","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2024.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2024.07.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}